Pierre Kemula

Director of Finance/CFO en CUREVAC N.V. .

Fortuna: 182 520 $ al 30/04/2024

50 años

Health Technology

Consumer Services

Cargos activos de Pierre Kemula

Empresas	Cargo	Inicio	Fin
CUREVAC N.V.	Director of Finance/CFO	01/11/2016	-
CureVac SE CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.	Director of Finance/CFO	01/01/2016	-

Empresas	Cargo	Inicio	Fin
PIXIUM VISION	Director of Finance/CFO	01/05/2014	16/02/2017
IPSEN	Public Communications Contact	22/10/2009	01/01/2014
IPSEN	Treasurer	01/01/2008	01/01/2014

London School of Economics & Political Science

Undergraduate Degree

Internacional

Operativa

Director of Finance/CFO	3
Public Communications Contact	1
Treasurer	1

Sectorial

Health Technology	5
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	1
CureVac SE CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.	Health Technology

Empresas privadas

Health Technology